Patients who is diagnosed iliopsoas impingement after total hip arthroplasty
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients who have symptoms for more than 3 months 2.Patients who have continued pain even after taking NSAIDs for 6 week or more and who can not use NSAIDs for asthma and digestive tract ulcer 3. More than 20 years old 4. Other , patients who the doctor has determined that it is suitable for this clinical study
Exclusion criteria
Exclusion criteria: 1. Patients with abnormal platelet counts in peripheral blood 2. Person who smokes a lot(Brinkmanindex>600) 3. Treatment with anticoagulants(Warfarin) 4. Uncontrolled diabetes mellitus :HbA1c not lower than 9.0% according to latest laboratory data obtained within 14 days before registration 5. Patients with malignancy 6. Patients less than 6 months after onset of cardiac infarction or cerebral infarction 7. Predictive survival period is less than 1 year 8.Active infectious disease (HBV, HCV, HTLV-1, HIV, syphilis) 9.Dialysis patients 10. Compromised host 11. Requiring continued use of oral corticosteroid therapy 12. Less than 20 years old 13. Doctor has determined that it is not suitable for this clinical study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety | — |
Secondary
| Measure | Time frame |
|---|---|
| Usefulness | — |
Countries
Japan
Contacts
Juntendo Hospital, Juntendo university school of medicine Orthopedic Surgery